Defining curative endpoints for transfusion‐dependent β‐thalassemia in the era of gene therapy and gene editing

Abstract excerpt

β-thalassemia is a monogenic disease that results in varying degrees of anemia. In the most severe form, known as transfusion-dependent β-thalassemia (TDT), the clinical hallmarks are ineffective erythropoiesis and a requirement of regular, life-long red blood cell transfusions, with the development of secondary clinical complications such as iron overload, end-organ damage, and a risk of early mortality. With...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Hemoglobinopathies and Related Disorders
• Share to Iron Metabolism and Disorders
• Share to Parvovirus B19 Infection Studies